Australia's largest stock trading and investment forum Australia's #1 stock forum

NSB

Click for more information

5.13%

3.7¢ neuroscientific biopharmaceuticals ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2

First 2 Last

Share
Profile

Follow
the_contrarian

4,531 Posts.

297

27/02/22

16:58

Post #: 59853968
Share

Assuming continual spend, they'll be down to around $6m in the kitty at the end of March. What's the feeling on a CR before phase 1 trials?

Dr. Andrews has mentioned in a recent interview that they won't need it but it may be too good to refuse some extra cash before some decent news flow.

Thoughts?

NSB Price at posting: 28.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 24 more messages in this thread...

First 2 Last

Add NSB (ASX) to my watchlist

(20min delay)
Last 3.7¢		Change -0.002(5.13%)		Mkt cap ! $5.350M

Open	High	Low	Value	Volume
3.7¢	3.7¢	3.7¢	$2.255K	60.94K

Buyers (Bids)

No.	Vol.	Price($)
1	40	3.7¢

Sellers (Offers)

Price($)	Vol.	No.
3.8¢	12035	2

View Market Depth

No.	Vol.	Price($)
1	40	0.037
1	175000	0.036
1	57147	0.035
1	100000	0.034
3	163333	0.033

Price($)	Vol.	No.
0.038	12035	2
0.039	44787	3
0.040	50000	1
0.041	200000	1
0.043	40000	1

Last trade - 10.38am 27/09/2024 (20 minute delay)

NSB (ASX) Chart